ADHD Stimulant Misuse Under Review
High-frequency misuse remains associated with polysubstance use, while no studies evaluated long-term physical health outcomes.
By
Kathryn Wighton
July 17, 2026
Clinical Scorecard: ADHD Stimulant Misuse Under Review
At a Glance
Category Detail
Condition ADHD Stimulant Misuse Key Mechanisms Patterns of misuse, acquisition routes, and health consequences of ADHD stimulant medications. Target Population US adults, particularly younger adults aged 18-30. Care Setting Public health and substance use research.
Key Highlights
Misuse of ADHD stimulants declined among younger adults, particularly from 2022 to 2023. 1.4% of Americans aged 12 and older reported misuse of ADHD stimulant medications in 2023. High-frequency misuse is associated with higher rates of polysubstance use. Most misuse episodes were oral and infrequent, averaging 4.5 days in the past month. Intentional stimulant misuse is linked to higher critical care and psychiatric admission rates. Guideline-Based Recommendations
Diagnosis
Monitor patterns of stimulant misuse among adults. Management
Address reasons for misuse, including concentration and alertness. Monitoring & Follow-up
Track health outcomes related to stimulant misuse, particularly in high-frequency users. Risks
Consider the co-occurrence of stimulant misuse with other substance use. Patient & Prescribing Data
Adults aged 18-30, particularly those in university settings.
High-frequency users are more likely to obtain stimulants from physicians or dealers.
Clinical Best Practices
Utilize comprehensive assessments to understand misuse patterns. Encourage toxicologic confirmation for self-reported misuse data. Investigate long-term health outcomes of stimulant misuse. Related Resources & Content
